Adalimumab in severe and acute sciatica: a multicenter, randomized, double-blind, placebo-controlled trial.

@article{Genevay2010AdalimumabIS,
  title={Adalimumab in severe and acute sciatica: a multicenter, randomized, double-blind, placebo-controlled trial.},
  author={St{\'e}phane Genevay and Sebastien Viatte and Axel Finckh and Pascal Zufferey and Federico Balagu{\'e} and Cem Gabay},
  journal={Arthritis and rheumatism},
  year={2010},
  volume={62 8},
  pages={2339-46}
}
OBJECTIVE Based on several experimental results and on a preliminary study, a trial was undertaken to assess the efficacy of adalimumab, a tumor necrosis factor alpha inhibitor, in patients with radicular pain due to lumbar disc herniation. METHODS A multicenter, double-blind, randomized controlled trial was conducted between May 2005 and December 2007 in Switzerland. Patients with acute (duration of <12 weeks) and severe (Oswestry Disability Index score of >50) radicular leg pain and imaging… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 22 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 36 references

[Cross-cultural validation of the Oswestry disability index in French].

Annales de readaptation et de medecine physique : revue scientifique de la Societe francaise de reeducation fonctionnelle de readaptation et de medecine physique • 2008
View 1 Excerpt

Surgery versus prolonged conservative treatment for sciatica.

The New England journal of medicine • 2007
View 2 Excerpts

Similar Papers

Loading similar papers…